Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: Correlation with induction of heme oxygenase 1

Journal of Immunology

Volumn 161, Issue 2, 1998, Pages 978-984

  Colville Nash, Paul R ^a   Qureshi, Saima S ^a   Willis, Dean ^a   Willoughby, Derek A ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN; HEME OXYGENASE; NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; KNOCKOUT MOUSE; LIGAND BINDING; NONHUMAN; PEROXISOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; TARGET CELL;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENZYME INDUCTION; HEME OXYGENASE (DECYCLIZING); MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICROBODIES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PROSTAGLANDIN D2; PROSTAGLANDINS, SYNTHETIC; PROTOPORPHYRINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 0032528350     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Vane, J. R. 1971. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol. 231:232.
2. Appleton, I., A. Tomlinson, and D. A. Willoughby. 1995. Induction of cyclooxygenase and nitric oxide synthase in inflammation. Adv. Pharmacol. 35:27.
3. Polla, B. S., and A. Cossarizza. 1996. Stress proteins in inflammation. In Stress-Inducible Cellular Responses. U. Feige, R. I. Morimoto, I. Yahara and B. Polla, eds. Birkhauser Verlag, Basel, p. 375.
4. Willis, D., A. R. Moore, R. Frederick, and D. A. Willoughby. 1997. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat. Med. 2:87.
5. Amici, C., L. Sistonen, M. G. Santoro, and R. I. Morimoto. 1992. Antiproliferative prostaglandins activate heat shock transcription factor. Proc. Natl. Acad. Sci. USA 89:6227.
6. Kliewer, S. A., J. M. Lenhard, T. M. Willson, I. Patel, D. C. Morris, and J. M. Lehmann. 1995. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83:813.
7. Lemberger, T., B. Desvergne, and W. Wahli. 1996. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu. Rev. Cell Dev. Biol. 12:335.
8. Schoonjans, K., B. Staels, and J. Auwerx. 1996. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta 1302:93.
9. Dreyer, C., G. Krey, H. Keller, F. Givel, G. Helftenbein, and W. Wahli. 1992. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68:879.
10. Hertz, R., M. Seckbach, M. M. Zakin, and J. Bar-Tana. 1996. Transcriptional suppression of the transferrin gene by hypolipidemic peroxisome proliferators. J. Biol. Chem. 271:218.
11. Motojima, K., S. Goto, and T. Imanaka. 1992. Specific repression of transthyretin gene expression in rat liver by a peroxisome proliferator clofibrate. Biochem. Biophys. Res. Commun. 188:799.
12. Elia, G., C. Amici, A. Rossi, and M. G. Santoro. 1996. Modulation of prostaglandin A1-induced thermotolerance by quercetin in human leukemic cells: role of heat shock protein 70. Cancer Res. 56:210.
13. Koizumi, T., M. Negishi, and A. Ichikawa. 1992. Induction of heme oxygenase by delta 12-prostaglandin J2 in porcine aortic endothelial cells. Prostaglandins 43:121.
14. Huang, Q., K. Alvares, R. Chu, C. A. Bradfield, and J. K. Reddy. 1994. Association of peroxisome proliferator-activated receptor and Hsp72. J. Biol. Chem. 269:8493.
15. Devchand, P. R., H. Keller, J. M. Peters, M. Vazquez, F. J. Gonzalez, and W. Wahli. 1996. The PPARalpha-leukotriene B4 pathway to inflammation control. Nature 384:39.
16. Ralph, P., and I. Nakoinz. 1977. Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPS. J. Immunol. 119:950.
17. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407.
18. Mossman, T. 1983. Rapid colorimetric assay for cellular growth and survival; application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55.
19. Willoughby, D. A., A. Tomlinson, D. Gilroy, and D. Willis. 1996. Inducible enzymes with special reference to COX-2 in the inflammatory response. In Improved Non-Steroid Anti-Inflammatory Drugs: COX-2 Enzyme Inhibitors. J. R. Vane, J. Botting, and R. Botting, eds. Kluwer Academic Publishers and William Harvey Press, Dordrecht/Boston/London, p. 67.
20. Aeberhard, E. E., S. A. Henderson, N. S. Arabolos, J. M. Griscavage, F. E. Castro, C. T. Barrett, and L. J. Ignarro. 1995. Non-steroidal anti-inflamatory drugs inhibit the expression of the inducible nitric oxide synthase gene. Biochem. Biophys. Res. Commun. 208:1053.
21. Schmidt, H. H. W., R. Seifert, and E. Bohme. 1989. Formation and release of nitric oxide from human neutrophils and HL-60 cells induced by a chemotactic peptide, platelet activating factor and leukotriene B4. FEBS Lett. 244: 357.
22. Hulkower, K. I., J. S. Pollock, R. E. Walsh, R. Huang, E. R. Otis, C. D. Brooks, Bell, and RL. 1996. Leukotrienes do not regulate nitric oxide production in RAW 264.7 macrophages. Prostaglandins Leukotrienes Essent. Fatty Acids 55:145.
23. Kliewer, S. A., B. M. Forman, B. Blumberg, E. S. Ong, U. Borgmeyer, Mangelsdorf, DJ, K. Umesono, and R. M. Evans. 1994. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA 91:7155.
24. Willson, T. M., J. M. Lehmann, and S. A. Kliewer. 1996. Discovery of ligands for the nuc lear peroxisome proliferator-activated receptors. Ann. N Y Acad. Sci. 804:276.
25. 2 regulates inducible nitric oxide synthase in the murine macrophage cell line J774. Prostaglandins 49:105.
26. 2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83:803.
27. Willis, D., A. Tomlinson, R. Frederick, M. J. Paul-Clark, and D. A. Willoughby. 1995. Modulation of heme oxygenase activity in rat brain and spleen by inhibitors of nitric oxide. Biochem. Biophys. Res. Commun. 214:1152.
28. Santoro, M. G., E. Garaci, and C. Amia. 1991. Induction of heat shock protein by prostaglandins with antineoplastic and antiviral activity. Adv. Prostaglandin Thromboxane Leukotriene Res. 21:867.
29. Trakshel, G. M., R. K. Kutty, and M. D. Maines. 1986. Purification and characterization of the major constitutive form of testicular heme oxygenase: the non-inducible isoform. J. Biol. Chem. 261:11131.
30. Ledwith, B. J., C. J. Pauley, L. K. Wagner, C. L. Rokos, D. W. Alberts, and S. Manam. 1997. Induction of cyclooxygenase-2 expression by peroxisome proliferators and non-tetradecanoylphorbol 12,13-myristate-type tumor promoters in immortalized mouse liver cells. J. Biol. Chem. 272:3707.
31. Reddy, S. T., and H. R. Herschman. 1997. Prostaglandin synthase-1 and prostaglandin synthase-2 are coupled to distinct phospholipases for the generation of prostaglandin D2 in activated mast cells. J. Biol. Chem. 272:3231.
32. 2. Prostaglandins Leukotrienes Med. 16:131.
33. Maines, M. D. 1981. Zinc protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal rat. Biochem. Biophys. Acta 673:339.
34. Maines, M. D. 1988. Heme oxygenase: function, multiplicity, regulatory mechanisms and clinical applications. FASEB J. 2:2557.
35. Cahill, C. M., W. R. Waterman, Y. Xie, P. E. Auron, and S. K. Calderwood. 1996. Transcriptional repression of the prointerleukin-1β gene by heat shock factor 1. J. Biol. Chem. 271:24874.
36. DeVera, M. E., Y. M. Kim, H. R. Wong, Q. Wang, T. R. Billiar, and D. A. Geller. 1996. Heat shock response inhibits cytokine inducible nitric oxide synthase expression in rat hepatocytes. Hepatology 24:1238.
37. Feinstein, D. L., E. Galea, D. A. Aquino, G. C. Li, H. Xu, and D. J. Reis. 1996. Heat shock protein 70 suppresses astroglial inducible nitric oxide synthase expression by decreasing NFkB activation. J. Biol. Chem. 271:17724.
38. Kurata, S., M. Matsumoto, and U. Yamashita. 1996. Concomitant transcriptional activation of nitric oxide synthase and heme oxygenase genes during nitric oxide mediated macrophage cytostasis. J. Biochem. (Tokyo) 120:49.
39. Xie, Q. W., Y. Kashiwabara, and C. Nathan. 1994. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:4705.
40. Fukushima, M. 1992. Biological activities and mechanisms of action of PGJ2 and related compounds: an update. Prostaglandins Leukotrienes Essent. Fatty Acids 47:1.
41. 2 formation and characterization of its synthetases in various tissues of adult rats. Arch. Biochem. Biophys. 260:521.